Watanabe K, Niikura N, Kikawa Y, Oba M, et al. Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial). Breast Cancer Res Treat 2023 Mar 31. doi: 10.1007/s10549-023-06911.
PMID: 37000345